Adamax
“Enhanced Semax” according to marketing; the published evidence is essentially that of Semax, not Adamax.
Updated:
Affiliate link to this product’s page on Peptira. We may earn a commission at no extra cost to you. Code KAREL. Disclosure
Quick summary
Adamax circulates as an N-acetylated / adamantylated version of Semax for greater stability or penetration. On PubMed, there are practically no trials of the “Adamax” compound. The honest approach is: anchor to Semax and admit that the modification is not clinically validated.
Studied for
How it works
Presumably similar to Semax (stabilized ACTH 4-10 fragment): modulation of BDNF and monoaminergic systems in models — not demonstrated for Adamax.
What the research says
The background is the Semax literature on PubMed. Adamax: minimal or absent literature; there is no basis to claim dose equivalence or superiority.
Evidence level
D — almost total gap for Adamax; Semax has Russian/regional literature
What's most reported
- Community: focus/mental energy (anecdotal)
- Semax (not Adamax): regional clinical literature in Russia
Common side effects
Specifically unknown. Possible nasal irritation if used via the mucosal route like Semax. Extrapolations are unreliable.
Combines / does not combine
Like Semax+Selank stacks: speculative. See Semax/Selank sheet.
Frequently asked questions
There is no published clinical comparison that demonstrates it.
Demand for peptide nootropics; this does not equate to evidence.
Keep exploring
Keep learning
Related peptides
Educational content. Not medical advice or usage guidance. Research products are not approved medications unless otherwise indicated.